Counterregulatory Effects of Interferon-gamma and Endotoxin on Expression of the Human C4 Genes

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1990 Mar 1

PMID 2107212

Citations 18

Authors

J Kulics

H R Colten

D H Perlmutter

Affiliations

Soon will be listed here.

Abstract

Susceptibility to autoimmune disease is associated with null alleles at one of the two genetic loci encoding complement protein C4. These two genetic loci, C4A and C4B, are highly homologous in primary structure but encode proteins with different functional activities. Expression of C4A and C4B genes is regulated by IFN-gamma in human hepatoma cells and in murine fibroblasts transformed with the respective genes. In these cell lines, IFN-gamma has a significantly greater and longer-lasting effect on expression of C4A than that of C4B. In this study we examined synthesis and regulation of C4A and C4B in peripheral blood monocytes from normal, C4A-null, and C4B-null individuals. Synthesis of C4 in human peripheral blood monocytes decreases during time in culture. IFN-gamma mediates a concentration- and time-dependent increase in steady-state levels of C4 mRNA and a corresponding increase in synthesis of C4 in normal human monocytes. LPS decreases monocyte C4 expression and completely abrogates the effect of IFN-gamma on the expression of this gene. In contrast, LPS and IFN-gamma have a synergistic effect in upregulating expression of another class III MHC gene product, complement protein factor B. The effect of LPS on constitutive and IFN-gamma-regulated C4 synthesis is probably not mediated via release of endogenous monokines IL-1 beta, TNF-alpha, or IL-6. Synthesis of C4, and regulation of its synthesis by IFN-gamma and LPS, are similar in normal, C4A-, and C4B-null individuals. These results demonstrate the synthesis of C4 at extrahepatic sites and tissue-specific regulation of C4 gene expression.

Citing Articles

Complement C4-deficient mice have a high mortality rate during PTZ-induced epileptic seizures, which correlates with cognitive problems and the deficiency in the expression of Egr1 and other immediate early genes.

Veremeyko T, Jiang R, He M, Ponomarev E Front Cell Neurosci. 2023; 17:1170031.

PMID: 37234916 PMC: 10206007. DOI: 10.3389/fncel.2023.1170031.

Attenuated transcriptional response to pro-inflammatory cytokines in schizophrenia hiPSC-derived neural progenitor cells.

Bhat A, Irizar H, Couch A, Raval P, Duarte R, Polit L Brain Behav Immun. 2022; 105:82-97.

PMID: 35716830 PMC: 9810540. DOI: 10.1016/j.bbi.2022.06.010.

The intron-enriched HERV-K(HML-10) family suppresses apoptosis, an indicator of malignant transformation.

Broecker F, Horton R, Heinrich J, Franz A, Schweiger M, Lehrach H Mob DNA. 2016; 7:25.

PMID: 27980690 PMC: 5142424. DOI: 10.1186/s13100-016-0081-9.

Overview of complement activation and regulation.

Noris M, Remuzzi G Semin Nephrol. 2013; 33(6):479-92.

PMID: 24161035 PMC: 3820029. DOI: 10.1016/j.semnephrol.2013.08.001.

Resistant arterial hypertension is associated with higher blood levels of complement C3 and C-reactive protein.

Magen E, Mishal J, Paskin J, Glick Z, Yosefy C, Kidon M J Clin Hypertens (Greenwich). 2008; 10(9):677-83.

PMID: 18844762 PMC: 8673401. DOI: 10.1111/j.1751-7176.2008.00002.x.

References

Awdeh Z, Alper C . Inherited structural polymorphism of the fourth component of human complement. Proc Natl Acad Sci U S A. 1980; 77(6):3576-80. PMC: 349660. DOI: 10.1073/pnas.77.6.3576. View

Katz Y, Cole F, Strunk R . Synergism between gamma interferon and lipopolysaccharide for synthesis of factor B, but not C2, in human fibroblasts. J Exp Med. 1988; 167(1):1-14. PMC: 2188816. DOI: 10.1084/jem.167.1.1. View

Newell S, Shreffler D, Atkinson J . Biosynthesis of C4 by mouse peritoneal macrophages. I. Characterization of an in vitro culture system and comparison of C4 synthesis by "low" vs "high" C4 strains. J Immunol. 1982; 129(2):653-9. View

Stecher V, Morse J, Thorbecke G . Sites of production of primate serum proteins associated with complement system. Proc Soc Exp Biol Med. 1967; 124(2):433-8. DOI: 10.3181/00379727-124-31758. View

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

Passmore H, Shreffler D . A sex-limited serum protein variant in the mouse: inheritance and association with the H-2 region. Biochem Genet. 1970; 4(3):351-65. DOI: 10.1007/BF00485752. View

Roberts B, Paterson B . Efficient translation of tobacco mosaic virus RNA and rabbit globin 9S RNA in a cell-free system from commercial wheat germ. Proc Natl Acad Sci U S A. 1973; 70(8):2330-4. PMC: 433729. DOI: 10.1073/pnas.70.8.2330. View

Whaley K . Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes. J Exp Med. 1980; 151(3):501-16. PMC: 2185797. DOI: 10.1084/jem.151.3.501. View

Southern E . Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975; 98(3):503-17. DOI: 10.1016/s0022-2836(75)80083-0. View

10.

SANGER F, Nicklen S, Coulson A . DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977; 74(12):5463-7. PMC: 431765. DOI: 10.1073/pnas.74.12.5463. View

11.

Chirgwin J, Przybyla A, MacDonald R, Rutter W . Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979; 18(24):5294-9. DOI: 10.1021/bi00591a005. View

12.

WHITEHEAD A, Goldberger G, Woods D, Markham A, Colten H . Use of a cDNA clone for the fourth component of human complement (C4) for analysis of a genetic deficiency of C4 in guinea pig. Proc Natl Acad Sci U S A. 1983; 80(17):5387-91. PMC: 384261. DOI: 10.1073/pnas.80.17.5387. View

13.

Chan A, Atkinson J . Identification and structural characterization of two incompletely processed forms of the fourth component of human complement. J Clin Invest. 1983; 72(5):1639-49. PMC: 370452. DOI: 10.1172/JCI111123. View

14.

Chaplin D, Woods D, WHITEHEAD A, Goldberger G, Colten H, Seidman J . Molecular map of the murine S region. Proc Natl Acad Sci U S A. 1983; 80(22):6947-51. PMC: 390103. DOI: 10.1073/pnas.80.22.6947. View

15.

Carroll M, Campbell R, Bentley D, Porter R . A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B. Nature. 1984; 307(5948):237-41. DOI: 10.1038/307237a0. View

16.

Sztein M, Steeg P, Johnson H, Oppenheim J . Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons. J Clin Invest. 1984; 73(2):556-65. PMC: 425048. DOI: 10.1172/JCI111243. View

17.

Belt K, Carroll M, Porter R . The structural basis of the multiple forms of human complement component C4. Cell. 1984; 36(4):907-14. DOI: 10.1016/0092-8674(84)90040-0. View

18.

Isenman D, Young J . The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4. J Immunol. 1984; 132(6):3019-27. View

19.

Sackstein R, Colten H . Molecular regulation of MHC class III (C4 and factor B) gene expression in mouse peritoneal macrophages. J Immunol. 1984; 133(3):1618-26. View

20.

Law S, DODDS A, Porter R . A comparison of the properties of two classes, C4A and C4B, of the human complement component C4. EMBO J. 1984; 3(8):1819-23. PMC: 557602. DOI: 10.1002/j.1460-2075.1984.tb02052.x. View